Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine

被引:14
作者
Brunner, Emily [1 ]
Levy, Robert [2 ]
机构
[1] Healtheast, St Paul, MN USA
[2] Univ Minnesota, Family Med & Community Hlth, Minneapolis, MN USA
关键词
designer drug; phenibut; phenobarbital;
D O I
10.1097/ADM.0000000000000303
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This case report describes the development of dependence to phenibut, a gamma-aminobutyric acid-receptor type B agonist, in a patient concurrently being treated with buprenorphine. The patient experienced withdrawal symptoms which were successfully treated with a phenobarbital taper based on a protocol to treat sedative use disorder. This case report provided an example of the development of a phenibut use disorder and also brought up a public health question of whether phenibut should therefore be officially classified and monitored.
引用
收藏
页码:239 / 240
页数:2
相关论文
共 5 条
[1]   Psychotic symptoms during phenibut (beta-phenyl-gamma-aminobutyric acid) withdrawal [J].
Hogberg, Lovisa ;
Szabo, Istvan ;
Ruusa, Jaan .
JOURNAL OF SUBSTANCE USE, 2013, 18 (04) :335-338
[2]  
Lapin I, 2001, CNS DRUG REV, V7, P471
[3]  
Mehilane LS, 1990, PHARM CLIN PHENIBUT
[4]   Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity [J].
Owen, David R. ;
Wood, David M. ;
Archer, John R. H. ;
Dargan, Paul I. .
DRUG AND ALCOHOL REVIEW, 2016, 35 (05) :591-596
[5]  
Samokhalov AV, 2013, BMJ CASE REP